Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Pediatric Thyroid Cancer Follow-up

  • Author: Mark E Gerber, MD; Chief Editor: Arlen D Meyers, MD, MBA  more...
 
Updated: Apr 30, 2015
 

Further Outpatient Care

Postoperative therapy

  • Radioactive iodine (RAI) therapy should be administered to all children and young adults with cervical lymphadenopathy after a total thyroidectomy to reveal and treat all distant metastases in the lungs. [14]
  • Thyroid hormone replacement with levothyroxine is started in the first few days after total thyroidectomy. This replacement is withheld in patients who will receive 131 I therapy. 131 I is administered only to patients with extensive neck disease or distant metastases.
  • Cytomel or synthetic T3 is often used in place of levothyroxine prior to a postoperative nuclear scan or radioactive iodine (RAI) treatment. Cytomel has a shorter half-life, minimizing the period in which no suppression or replacement occurs and maximizing the uptake of radionuclide used in the scan or radioiodine therapy. A control thyroid scan is usually performed 2-3 weeks after surgery or radioiodine therapy. TSH-suppressive doses (150-200 mcg/d of T4) are thought to decrease recurrence in differentiated carcinomas. [12]
  • Thyroid carcinoma has been found to recur up to 33 years after treatment. Patients should receive close follow-up care with pulmonary function tests, chest radiography, CT scans, and thyroid function tests. [61] Thyroglobulin levels should be monitored for indications of medullary carcinoma.
  • Postoperative local external beam radiation is not recommended because of a possible carcinogenic effect in children.
Next

Further Inpatient Care

Serum calcium levels are measured daily for the first 2-4 postoperative days in all patients who have undergone a total or subtotal thyroidectomy. The calcium level usually drops slightly (to about 7 mg/dL) as the remaining parathyroid tissue recovers from surgical trauma. Mild hypocalcemia of this level requires treatment only if symptomatic. Mild symptoms include a positive Trousseau or Chvostek sign, mild cardiac arrhythmia, or perioral tingling. Treatment of these mild symptoms requires only oral calcium combined with vitamin D. Intravenous calcium gluconate is used for a more rapid replacement with severe arrhythmia or impending tetany.

Previous
Next

Inpatient & Outpatient Medications

Perioperative antibiotics are often used, and postoperative pain medications are standard, in addition to suppressive or replacement T4.

Previous
Next

Complications

Surgical complications include recurrent laryngeal nerve injury, hypoparathyroidism, hypothyroidism, and wound infection.

  • The most common complication of a total thyroidectomy in children is parathyroid gland injury. In 6-15% of patients, parathyroid gland injury results in permanent hypoparathyroidism. [59, 25, 42]
  • Hypothyroidism in all patients after total thyroidectomy is avoided with thyroid hormone replacement.
  • Hypothyroidism occurs in 6.5-49% of patients who have undergone subtotal thyroidectomy.
  • Secondary operations are more hazardous. [57]
Previous
Next

Prognosis

Whereas the degree of invasion and metastases corresponds to prognosis in adults, this relationship is not seen in the pediatric population. In fact, the presence of lymph nodes does not affect the prognosis in children and adolescents.[14] The reason for this is multifactorial and can be attributed to an overwhelming majority of well-differentiated cancers, low incidence of bone metastasis, and excellent response to RAI.

  • Bone metastasis also has a low incidence in childhood thyroid cancers, occurring in less then 5% of patients.
  • Individuals with radiation-induced thyroid cancer are at an increased risk for additional cancer later in life. [35]

Pediatric patients have higher local and distant recurrence rates than adults, but they tend to respond rapidly to therapy. The prognosis is excellent in children, with mortality rates of less than 10%.

The overall 20-year survival rate is 92-100%.

Some studies report young age as the major determinant of recurrence in pediatric-differentiated thyroid carcinoma, which suggests a difference in tumor biology.

Rearrangements in the ret protooncogene have been observed in those exposed to radiation, with a reported ret rearrangement rate between 50 and 70%.[24] Williams et al studied Chernobyl-induced thyroid tumor behavior and found that thyroid tumors associated with the ret and PTC3 oncogenes were more aggressive, faster growing, and less differentiated.[21] Thyroid tumors with the ret/PTC1 oncogene had more benign characteristics and were slower growing.

Previous
 
Contributor Information and Disclosures
Author

Mark E Gerber, MD Clinical Associate Professor of Surgery, University of Chicago Pritzker School of Medicine; Division Head, Otolaryngology-Head and Neck Surgery; Director, Pediatric Otolaryngology-Head and Neck Surgery, NorthShore University Health System

Mark E Gerber, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Bronchoesophagological Association, American Society of Pediatric Otolaryngology, Society for Ear, Nose and Throat Advances in Children, American Academy of Pediatrics, American Rhinologic Society

Disclosure: Nothing to disclose.

Coauthor(s)

Brian Kip Reilly, MD Assistant Professor of Otolaryngology and Pediatrics, Department of Otolaryngology, Children's National Medical Center, George Washington University School of Medicine

Brian Kip Reilly, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Mihir K Bhayani, MD Clinical Assistant Professor, Department of Surgery, University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine; Consulting Surgeon, Head and Neck Surgical Oncology Section, Department of Otolaryngology, NorthShore University Health System

Mihir K Bhayani, MD is a member of the following medical societies: American Head and Neck Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Nader Sadeghi, MD, FRCSC Professor, Otolaryngology-Head and Neck Surgery, Director of Head and Neck Surgery, George Washington University School of Medicine and Health Sciences

Nader Sadeghi, MD, FRCSC is a member of the following medical societies: American Head and Neck Society, American Thyroid Association, American Academy of Otolaryngology-Head and Neck Surgery, Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;SymbiaAllergySolutions<br/>Received income in an amount equal to or greater than $250 from: Symbia<br/>Received from Allergy Solutions, Inc for board membership; Received honoraria from RxRevu for chief medical editor; Received salary from Medvoy for founder and president; Received consulting fee from Corvectra for senior medical advisor; Received ownership interest from Cerescan for consulting; Received consulting fee from Essiahealth for advisor; Received consulting fee from Carespan for advisor; Received consulting fee from Covidien for consulting.

Acknowledgements

Russell A Faust, MD, PhD Consulting Staff, Department of Otolaryngology, Columbus Children's Hospital

Disclosure: Nothing to disclose.

References
  1. [Guideline] Francis G, Waguespack SG, Bauer AJ, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer. Thyroid. 2015 Apr 21. [Medline]. [Full Text].

  2. Busko M. ATA Issues First Advice for Thyroid Nodules, Cancer in Children. Medscape Medical News. Apr 27 2015. [Full Text].

  3. Albright JT, Topham AK, Reilly JS. Pediatric head and neck malignancies: US incidence and trends over 2 decades. Arch Otolaryngol Head Neck Surg. 2002 Jun. 128(6):655-9. [Medline].

  4. Corrias A, Mussa A. Thyroid Nodules in Pediatrics: Which Ones Can Be Left Alone, Which Ones Must be Investigated, When and How. J Clin Res Pediatr Endocrinol. 2013 March. 5(Suppl 1):57–69. [Medline].

  5. Silverman SH, Nussbaum M, Rausen AR. Thyroid nodules in children: a ten year experience at one institution. Mt Sinai J Med. 1979 Sep-Oct. 46(5):460-3. [Medline].

  6. Ridgway EC. Clinician Evaluation of a Solitary Thyroid Nodules. Journal of Clinical Endocrinology and Metaoblism. 1992. Vol. 74, No. 2:231-235.

  7. Niedziela M, Korman E. Thyroid carcinoma in a fourteen-year-old boy with Graves disease. Med Pediatr Oncol. 2002 Apr. 38(4):290-1. [Medline].

  8. Halac I, Zimmerman D. Thyroid nodules and cancers in children. Endocrinol Metab Clin North Am. 2005 Sep. 34(3):725-44, x. [Medline].

  9. Festen C, Otten BJ, van de Kaa CA. Follicular adenoma of the thyroid gland in children. Eur J Pediatr Surg. 1995 Oct. 5(5):262-4. [Medline].

  10. Schneider K. Sonographic imaging of the thyroid in children. Prog Pediatr Surg. 1991. 26:1-14. [Medline].

  11. Sherman NH, Rosenberg HK, Heyman S, et al. Ultrasound evaluation of neck masses in children. J Ultrasound Med. 1985 Mar. 4(3):127-34. [Medline].

  12. Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children: diagnosis and management. Curr Opin Oncol. 2008 Jan. 20(1):59-65. [Medline].

  13. Garcia CJ, Daneman A, Thorner P, et al. Sonography of multinodular thyroid gland in children and adolescents. Am J Dis Child. 1992 Jul. 146(7):811-6. [Medline].

  14. Rapkin L, Pashankar FD. Management of thyroid carcinoma in children and young adults. J Pediatr Hematol Oncol. 2012 May. 34 Suppl 2.:S39-46. [Medline].

  15. Khurana KK, Labrador E, Izquierdo R, et al. The role of fine-needle aspiration biopsy in the management of thyroid nodules in children, adolescents, and young adults: a multi-institutional study. Thyroid. 1999 Apr. 9(4):383-6. [Medline].

  16. Lugo-Vicente H, Ortiz VN, Irizarry H, et al. Pediatric thyroid nodules: management in the era of fine needle aspiration. J Pediatr Surg. 1998 Aug. 33(8):1302-5. [Medline].

  17. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer. 2006 Jun. 13(2):427-53. [Medline].

  18. Corrias A, Cassio A, Weber G, et al. Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med. 2008 Jun. 162(6):526-31. [Medline].

  19. Zimmerman, D. Thyroid Carcinoma in Children and Adolescents: diagnostic implications of analysis of the tumor genome. Curr Opin Pediatr. 25:[Medline].

  20. Miccoli P, Minuto MN, Ugolini C, et al. Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age. Otolaryngol Head Neck Surg. 2008 Feb. 138(2):200-3. [Medline].

  21. Williams ED, Abrosimov A, Bogdanova T, et al. Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br J Cancer. 2004 Jun 1. 90(11):2219-24. [Medline].

  22. Ron E. Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys. 2007 Nov. 93(5):502-11. [Medline].

  23. Yoskovitch A, Laberge JM, Rodd C, et al. Cystic thyroid lesions in children. J Pediatr Surg. 1998 Jun. 33(6):866-70. [Medline].

  24. Alessandri AJ, Goddard KJ, Blair GK, et al. Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Med Pediatr Oncol. 2000 Jul. 35(1):41-6. [Medline].

  25. La Quaglia MP, Telander RL. Differentiated and medullary thyroid cancer in childhood and adolescence. Semin Pediatr Surg. 1997 Feb. 6(1):42-9. [Medline].

  26. Attie JA. Carcinoma of the thyroid in children and adolescents. F Lifshitz. Pediatric Endocrinology. 3. New York: Marcel Dekker; 1996. 423-432.

  27. Estevao-Costa J, Gil-Da-Costa MJ, Medina AM, et al. Thyroid carcinoma in a newborn: clinical challenges in managing the first recorded case. Med Pediatr Oncol. 2000 Apr. 34(4):290-2. [Medline].

  28. Yip FW, Reeve TS, Poole AG, et al. Thyroid nodules in childhood and adolescence. Aust N Z J Surg. 1994 Oct. 64(10):676-8. [Medline].

  29. Skinner MA, Wells SA Jr. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes. Semin Pediatr Surg. 1997 Aug. 6(3):134-40. [Medline].

  30. Cotterill SJ, Pearce MS, Parker L. Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident?. Eur J Cancer. 2001 May. 37(8):1020-6. [Medline].

  31. Gawrysiak W, Niedziela M. Suppurative thyroiditis. Endokrynologia Pediatryczna (Pediatric Endocrinology). 2005. 4:65-69.

  32. Bhatia S, Ramsay NK, Bantle JP, et al. Thyroid Abnormalities after Therapy for Hodgkin's Disease in Childhood. Oncologist. 1996. 1(1 & 2):62-67. [Medline].

  33. Jensen MO, Antonenko D. Thyroid and thymic malignancy following childhood irradiation. J Surg Oncol. 1992 Jul. 50(3):206-8. [Medline].

  34. Metayer C, Lynch CF, Clarke EA, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol. 2000 Jun. 18(12):2435-43. [Medline].

  35. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus. Cancer. 1994 Jul 15. 74(2):748-66. [Medline].

  36. Vane D, King DR, Boles ET Jr. Secondary thyroid neoplasms in pediatric cancer patients: increased risk with improved survival. J Pediatr Surg. 1984 Dec. 19(6):855-60. [Medline].

  37. Thomas GA, Bunnell H, Cook HA, et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab. 1999 Nov. 84(11):4232-8. [Medline].

  38. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000 Sep. 85(9):3227-32. [Medline].

  39. Patti G, Ragni G, Calisti A. Papillary thyroid carcinoma in a thyroglossal duct cyst in a child. Med Pediatr Oncol. 2000 Jan. 34(1):67-9. [Medline].

  40. Luboshitzky R, Lavi I, Ishay A. Serum thyroglobulin levels after fine-needle aspiration of thyroid nodules. Endocr Pract. 2006 May-Jun. 12(3):264-9. [Medline].

  41. Bockhorn M, Frilling A, Rewerk S, et al. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid. 2004 Jun. 14(6):468-70. [Medline].

  42. Telander RL, Moir CR. Medullary thyroid carcinoma in children. Semin Pediatr Surg. 1994 Aug. 3(3):188-93. [Medline].

  43. Bajpai M, Ramaswamy S, Gupta DK, et al. Solitary thyroid nodule. Indian Pediatr. 1992 Jan. 29(1):116-8. [Medline].

  44. Solbiati L, Cioffi V, Ballarati E. Ultrasonography of the neck. Radiol Clin North Am. 1992 Sep. 30(5):941-54. [Medline].

  45. Hegedüs L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003 Feb. 24(1):102-32. [Medline].

  46. Harach HR, Sanchez SS, Williams ED. Pathology of the autonomously functioning (hot) thyroid nodule. Ann Diagn Pathol. 2002 Feb. 6(1):10-9. [Medline].

  47. Croom RD 3rd, Thomas CG Jr, Reddick RL, et al. Autonomously functioning thyroid nodules in childhood and adolescence. Surgery. 1987 Dec. 102(6):1101-8. [Medline].

  48. Geiger JD, Thompson NW. Thyroid tumors in children. Otolaryngol Clin North Am. 1996 Aug. 29(4):711-9. [Medline].

  49. Desjardins JG, Khan AH, Montupet P, et al. Management of thyroid nodules in children: a 20-year experience. J Pediatr Surg. 1987 Aug. 22(8):736-9. [Medline].

  50. Eisenhut CC, King DE, Nelson WA, et al. Fine-needle biopsy of pediatric lesions: a three-year study in an outpatient biopsy clinic. Diagn Cytopathol. 1996 Feb. 14(1):43-50. [Medline].

  51. Raab SS, Silverman JF, Elsheikh TM, et al. Pediatric thyroid nodules: disease demographics and clinical management as determined by fine needle aspiration biopsy. Pediatrics. 1995 Jan. 95(1):46-9. [Medline].

  52. Bettendorf M. Thyroid disorders in children from birth to adolescence. Eur J Nucl Med Mol Imaging. 2002 Aug. 29 Suppl 2:S439-46. [Medline].

  53. Gimm O, Sutter T, Dralle H. Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. J Cancer Res Clin Oncol. 2001. 127(3):156-65. [Medline].

  54. Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children: diagnosis and management. Curr Opin Oncol. 2008 Jan. 20(1):59-65. [Medline].

  55. AJCC Cancer Staging Manual. Sixth Edition. New York: Springer-Verlag, , Inc; 2002.

  56. Yeh SD, La Quaglia MP. 131I therapy for pediatric thyroid cancer. Semin Pediatr Surg. 1997 Aug. 6(3):128-33. [Medline].

  57. Bryarly RC, Shockley WW, Stucker FJ. The method and management of thyroid surgery in the pediatric patient. Laryngoscope. 1985 Sep. 95(9 Pt 1):1025-8. [Medline].

  58. Herzog B. Thyroid gland diseases and tumours. Surgical aspects. Prog Pediatr Surg. 1983. 16:15-22. [Medline].

  59. Lallier M, St-Vil D, Giroux M, et al. Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome. J Pediatr Surg. 1998 Jun. 33(6):846-8. [Medline].

  60. Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: determinants of disease progression in patients 1111111111111111Ann Surg</i>. 1998 Apr. 227(4):533-41. [Medline].

  61. Ben Arush MW, Stein ME, Perez Nahum M, et al. Pediatric thyroid carcinoma: 22 years of experience at the Northern Israel Oncology Center (1973-1995). Pediatr Hematol Oncol. 2000 Jan-Feb. 17(1):85-92. [Medline].

  62. Amrikachi M, Ponder TB, Wheeler TM, et al. Thyroid fine-needle aspiration biopsy in children and adolescents: experience with 218 aspirates. Diagn Cytopathol. 2005 Apr. 32(4):189-92. [Medline].

  63. Belfiore A, Giuffrida D, La Rosa GL, et al. High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh). 1989 Aug. 121(2):197-202. [Medline].

  64. Hughes CJ, Shaha AR, Shah JP, et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck. 1996 Mar-Apr. 18(2):127-32. [Medline].

  65. Millman B, Pellitteri PK. Nodular thyroid disease in children and adolescents. Otolaryngol Head Neck Surg. 1997 Jun. 116(6 Pt 1):604-9. [Medline].

  66. Salas M. Thyroid nodules in children and adolescents. Ed. F Lifshitz. In Pediatric Endocrinology, edn 3. New York: Marcel Dekker; 1995. pp 415-422.

 
Previous
Next
 
A monomorphous cell population of Hürthle cells arranged in loosely cohesive clusters and single cells. The cells are polyhedral and have abundant granular cytoplasm with well-defined cell borders. The nuclei are enlarged and have a central prominent macronucleolus.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.